The higher education expenditure on R&D in medical and health sciences in Italy is projected to rise from 1.27 billion USD PPP in 2024 to 1.33 billion USD PPP in 2028. In 2023, the expenditure was approximately 1.25 billion USD PPP. This represents a consistent annual increase of 0.02 billion USD PPP, equating to a year-on-year gain of roughly 1.57% on average over 2024-2028. The compound annual growth rate (CAGR) over this period is about 1.53%, indicating a steady investment in medical and health sciences.

Future trends to watch for:

Government policy shifts towards increased healthcare funding could bolster this trend.
Technological advancements in medical research may accelerate investment needs.
Collaborations with international institutions could enhance funding sources and innovation.